The 16^th Asia Pacific Biotechnology Congress was organized during August 15-16, 2018 at the Holiday Inn Singapore Atrium, Singapore. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group journals, scientists, young and brilliant researchers, business delegates and talented student communities representing more than 10 countries, who made this conference fruitful and productive.

This conference was based on the theme “Transcending the current frontiers of biotechnology” which included the following scientific tracks:  

• Medical Biotechnology
• Molecular Biotechnology
• Nutrition and Food Biotechnology
• Neuro Biotechnology
• Biochemistry and Cellular Biotechnology
• Environmental Biotechnology
• Cancer Biotechnology
• Aquaculture and Marine Biotechnology
• Agriculture Biotechnology
• Nano Biotechnology
• Biotechnology and Drug Design
• Bioinformatics
• Tissue Engineering and Regenerative Medicine
• Pharmaceutical Biotechnology
• Industrial Biotechnology
• Microbial Biotechnology and Applications
• Enzyme Technology
• Plant Biotechnology
• Bioenergy and Bioremediation
• Biotechnology and Bioengineering
• Protein Engineering
• Global Bioeconomy

Asia Pacific Biotechnology 2018 was moderated by Dr. Ashish Wadhwani (JSS Academy of Higher Education and Research, India).

We are grateful to our moderators and organizing committee members for their generous support and suggestions for the conference.

• Dr. Ashish Wadhwani (JSS Academy of Higher Education and Research, India)
• Auj-E Taqaddas – (Research Wormhole, Canada)

The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as keynote presentations:

• Novel exosome proteins as potential biomarkers for early detection of lung cancer: Lingzhi Wang, National University of Singapore, Singapore
• An e-survey of proton therapy in cancer treatment in USA: Auj-E Taqaddas, Research Wormhole, Canada
• Uncover the molecular mechanism that regulates the RAF/MEK/ERK kinase cascade by characterizing the oncogenic RAF/MEK mutants: Jiancheng Hu, National Cancer Centre Singapore, Singapore
• Sensitivity and role of MRI in diagnosis of retinoblastoma in comparison with histopathology: Eisha Tahir, Shalamar Hospital, Pakistan.

Scientific sessions were chaired and co chaired by: Lingzhi Wang, National University of Singapore, Singapore and Jiancheng Hu, National Cancer Centre Singapore, Singapore.

Conference Series LLC has taken the grand privilege of felicitating Asia Pacific Biotechnology 2018 organizing committee, editorial board members and keynote speakers who supported for the success of this event.

The esteemed guests, keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their presentations at the podium of Asia Pacific Biotechnology Congress 2018. We are glad to inform that all accepted abstracts for the conference have been published in the Journal of Tissue Science & Engineering as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the organizing committee members for their presence, support, and assistance. With the unique and positive feedback from the conference, Conference Series LLC would like to announce the commencement of the "25^th Asia Pacific Biotechnology Congress" which is being organized during May 01-02 at Kyoto, Japan.